Quarterly Consolidated Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7710952

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
As at
2018-03-31
As at
2017-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
3,459,000,000 JPY
11,729,000,000 JPY
Interest and dividends received
422,000,000 JPY
405,000,000 JPY
Interest paid
-64,000,000 JPY
-24,000,000 JPY
Income taxes paid
-3,476,000,000 JPY
-1,655,000,000 JPY
Net cash provided by (used in) operating activities
340,000,000 JPY
10,456,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,170,000,000 JPY
-3,387,000,000 JPY
Proceeds from sale of property, plant and equipment
23,000,000 JPY
91,000,000 JPY
Purchase of investment securities
-620,000,000 JPY
-7,099,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
JPY
-399,000,000 JPY
Proceeds from sale of shares of subsidiaries resulting in change in scope of consolidation
JPY
434,000,000 JPY
Other, net
-129,000,000 JPY
-146,000,000 JPY
Net cash provided by (used in) investing activities
14,939,000,000 JPY
-6,038,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
303,000,000 JPY
1,712,000,000 JPY
Repayments of long-term borrowings
-1,582,000,000 JPY
-1,297,000,000 JPY
Dividends paid
-5,068,000,000 JPY
-4,325,000,000 JPY
Net cash provided by (used in) financing activities
-27,315,000,000 JPY
-3,735,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-22,000,000 JPY
-210,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-12,057,000,000 JPY
471,000,000 JPY
Cash and cash equivalents
30,914,000,000 JPY
42,971,000,000 JPY
42,499,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.